The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.

Edward Damiano

President and CEO of Beta Bionics.

Ever since his now 19-year-old son David developed type 1 diabetes at 11 months of age, Ed D. has been committed to creating and integrating closed-loop blood-glucose control technologies with a vision of building a bionic pancreas by the time his son headed off to college. Between 2005 and 2008, he and his PhD student, Firas El-Khatib, began conducting experiments in diabetic pigs in his laboratory at Boston University testing an early laptop-version of their bionic pancreas system. They then progressed with their clinical collaborators at the Massachusetts General Hospital to conduct over four years in-patient trials in adults and adolescents with T1D. Over the past five years, his team at Boston University, along with his clinical collaborators, have conducted over a dozen outpatient and home-use clinical trials in adults and children with type 1 diabetes testing a mobile version of their bionic pancreas, which ran on an iPhone.

Visit website: https://www.betabionics.com/edamiano

See also

Beta Bionics

Medical device company creating solutions for people with diabetes.

Details last updated 12-Feb-2020

Edward Damiano News

FDA approves bionic pancreas for home-use study

FDA approves bionic pancreas for home-use study

Diabetes.co.uk - 22-May-2018

iLet uses an algorithm to known when to deliver insulin, glucagon or a combination of both

Bionic pancreas in successful human trial

Bionic pancreas in successful human trial

BBC - 31-Aug-2014

Mimics a real pancreas by delivering both insulin to lower blood sugar and glucagon to raise it.